UCSF

Akinyemi Oni-Orisan, PharmD, PhD

Assistant Professor
Anna Wu
Phone: +1 415 502-7551
Fax: +1 415 476-1356
513 Parnassus Avenue, MSB, Rm 966B
UCSF Box 0794
San Francisco, CA 94143
United States

Affiliations

What I do

My lab conducts computational research investigating therapies for cardiovascular disease using observational data from electronic health records. I also teach pharmacy students in the Discovery Projects research program including leading the Health Disparities Discovery Group and serving as a primary mentor for students in the Pharmacogenomics Discovery Group.

Departmental research area

My research expertise

pharmacogenomics, pharmacoepidemiology, clinical research in historically minoritized groups, electronic health records

Clinical expertise

cardiovascular disease risk reduction, lipid management

Professional background

Biography

The long-term research goal of Dr. Oni-Orisan’s lab is to improve pharmacological regimens for the prevention and treatment of cardiovascular disease in diverse populations through precision medicine. To accomplish this objective, his group combines computational approaches in pharmacogenomics and pharmacoepidemiology using electronic health record-linked biobanks. His lab is currently funded to investigate genetic determinants of efficacy and safety for statin therapy in diverse populations.

Dr. Oni-Orisan teaches and mentors pharmacy students in the Discovery Projects research program including leading the inaugural Health Disparities Discovery Group.

Dr. Oni-Orisan serves as Diversity Leader for the Department of Clinical Pharmacy to champion diversity, equity and inclusion (DEI) efforts in the department.

Research keywords

  • pharmacogenomics
  • health disparities
  • Cardiovascular drugs
  • Amino Acid Substitution
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Eicosanoids
  • Epoxide Hydrolases
  • Arachidonic Acids
  • Prostaglandin-Endoperoxide Synthases
  • precision medicine
  • Cholesterol, LDL
  • Arachidonic Acid
  • pharmacogenetics
  • Patient Acuity
  • Cardiotonic Agents
  • Cytochrome P-450 Enzyme System
  • Lovastatin
  • Acute Coronary Syndrome